AZN Related StreetInsider.com Reports
-
Optimer Pharmaceuticals (OPTR) Jumps as AstraZeneca (AZN), Cubist (CBST) Submit First Round Bids
-
Former AstraZeneca N.A. CEO to Serve as Senior Advisor to VIVUS (VVUS)
-
Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)
-
Streetinsider.com Pre-Open Movers 04/05: (XIDE) (NIHD) (NVAX) Higher; (RIGL) (FFIV) (SABA) Lower
-
AstraZeneca (AZN) Reports Statistically Significant Data from OSKIRA-1
-
Dupilumab Could End of Being 'Blockbuster' Asthma Drug - Analyst (SNY) (REGN)
-
Actavis (ACT) Receives Favorable Verdict in Generic Pulmicort Respules Patent Case
-
Actavis (ACT) Receives TRO on Sales of Pulmicort Respules
-
AstraZeneca (AZN) May Appeal Adverse Pulmicort Respules Litigation Verdict
-
Optimer Pharma (OPTR) Said to Draw Interest from Glaxo (GSK), Astellas
-
JPMorgan Upgrades AstraZeneca (AZN) to Neutral
-
Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation
-
Natixis Upgrades AstraZeneca (AZN) to Neutral
-
AstraZeneca (AZN) Updates on Growth Strategies; Plans tor Headcount Reduction
-
AstraZeneca (AZN) Enters RNA Agreement with Moderna Therapeutics
-
AstraZeneca (AZN) to Relocate R&D Center; Sees $1.4B in One-Time Charges
-
Targacept (TRGT) Enters New Modulator Collaboration Agreement w/ AstraZeneca (AZN)
-
AstraZeneca (AZN) Issues Encouraging Update from High-Level KODIAC-08 Trial
-
AstraZeneca's (AZN) Best Chance to Regain Profitability? One Major Acquisition...
-
AstraZeneca (AZN) Opens Lower After Reports Q4 Results
-
Trading Radar for 0131: Dow (DOW), MasterCard (MA), UPS (UPS), Viacom (VIAB), Under Armour (UA) Report
-
AstraZeneca (NYSE: AZN) Might Be Interested in Shire (SHPG)
-
AstraZeneca (AZN) Enters In-Lincensing Deal for Progenics' (PGNX) Clostridium Difficile Program
-
AstraZeneca (AZN) Receives Favorable Decision in Crestor Patent Appeal
-
AstraZeneca PLC (AZN) wins appeals court ruling on Crestor patent
-
Societe Generale Downgrades AstraZeneca (AZN) to Sell
-
Unusual 11 Mid-Day Movers 12/13: (ONCY) (PRGN) (SAM) Higher; (RIGL) (HG) (CSUN) Lower
-
Rigel Pharma (RIGL) Hit as OSKIRA-4 Misses Secondary Endpoint (AZN)
-
AstraZeneca (AZN) Updates on OSKIRA-4 Top-Line Results; Did Not Meet Secondary Objective
-
Isis (ISIS) and AstraZeneca (AZN) Team to Develope RNA Therapeutics
-
Notable 52-Week Highs and Lows of the Day 12/05: (BAC) (CP) (CYCC) High; (TIBX) (RECV) (RAD) Low
-
Mylan (MYL) Launches Generic Version of Astra's (AZN) Atacand HCT
-
AstraZeneca (AZN) Updates on Overall Survival from FASLODEX CONFIRM
-
AstraZeneca (AZN) to Present Key Data on FASLODEX® (fulvestrant)
-
Amarin (AMRN) Higher as Teva (TEVA) Said to be Waiting in the Wings for a Takeover
-
Bristol-Myers (BMY), AstraZeneca (AZN) Receive EC Approval for Forxiga
-
AstraZeneca (AZN) Reports Statistically Significant Phase III KODIAC Results
-
Amarin (AMRN) Shares Active as AstraZeneca (AZN) Tops Q3 Expectations
-
AstraZeneca (AZN) Tops Q3 EPS by 4c; Reaffirms FY12 Outlook
-
Trading Radar for 10/25: Apple (AAPL), Sprint (S), Amazon (AMZN), Clearwire (CLWR), Procter & Gamble (PG), Dunkin' Brands (DNKN), Expedia (EXPE) Report
-
Amarin (AMRN) Could See Action on Takeover Report
-
AstraZeneca (AZN), Ironwood (IRWD) Enter Linaclotide co-Development Agreement
-
AstraZeneca (AZN) Picks Charles River Labs (CRL) for DMPK Safety Assessment Work
-
AstraZeneca (AZN), Ardelyx Enter NH3 Inhibitor Licensing Program
-
Is AstraZeneca (AZN) Preserving Cash for a Forest Labs (FRX) Bid?
-
AstraZeneca (AZN) Suspends Buybacks; Aims to Maintain Financial Flexibility
-
AstraZeneca PLC (AZN) to suspend share repurchase program immediately.
-
Trading Radar for 09/27: RIM (RIMM), Nike (NKE), Discover Financial (DFS), AstraZeneca (AZN) Report
-
Notable Analyst Rating Changes 09/19: (ACHN) (GLW) (AZN) Upgraded; (IDIX) (WM) (SCHW) Downgraded
-
Exane BNP Paribas Upgrades AstraZeneca (AZN) to Neutral
Back to AZN Stock Lookup
